The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. (Q37365776)

From Wikidata

Revision as of 17:19, 9 November 2020 by Charles Matthews (talk | contribs) (‎Changed claim: main subject (P921): T-lymphocytes (Q193529))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on 30 September 2013

Language	Label	Description	Also known as
English	The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.	scientific article published on 30 September 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

review article

1 reference

stated in

PubMed

retrieved

22 July 2020

title

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

main subject

patient

0 references

programmed cell death 1

1 reference

stated in

PubMed

retrieved

31 July 2019

T-lymphocytes

1 reference

stated in

PubMed

retrieved

12 October 2019

hemic and immune systems

1 reference

stated in

PubMed

retrieved

18 October 2019

CD274 molecule

1 reference

stated in

PubMed

retrieved

15 December 2019

tumor of hematopoietic and lymphoid tissues

1 reference

stated in

PubMed

retrieved

22 July 2020

author name string

Li Shi

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

Shaohua Chen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

Lijian Yang

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

Yangqiu Li

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

publication date

30 September 2013

9 references

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

18 June 2019

stated in

PubMed Central

retrieved

19 June 2019

stated in

PubMed Central

retrieved

31 July 2019

stated in

PubMed Central

retrieved

12 October 2019

stated in

PubMed Central

retrieved

18 October 2019

stated in

PubMed Central

retrieved

15 December 2019

stated in

PubMed Central

retrieved

22 July 2020

published in

Journal of Hematology & Oncology

9 references

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

stated in

PubMed Central

retrieved

3 April 2019

stated in

PubMed Central

retrieved

18 June 2019

stated in

PubMed Central

retrieved

19 June 2019

stated in

PubMed Central

retrieved

31 July 2019

stated in

PubMed Central

retrieved

12 October 2019

stated in

PubMed Central

retrieved

18 October 2019

stated in

PubMed Central

retrieved

15 December 2019

stated in

PubMed Central

retrieved

22 July 2020

volume

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

page(s)

74

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

8 references

stated in

Europe PubMed Central

retrieved

3 April 2019

stated in

Europe PubMed Central

retrieved

18 June 2019

stated in

Europe PubMed Central

retrieved

19 June 2019

stated in

Europe PubMed Central

retrieved

31 July 2019

stated in

Europe PubMed Central

retrieved

12 October 2019

stated in

Europe PubMed Central

retrieved

18 October 2019

stated in

Europe PubMed Central

retrieved

15 December 2019

stated in

Europe PubMed Central

retrieved

22 July 2020

on focus list of Wikimedia project

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1756-8722-6-74

0 references

cites work

Cellular immunotherapy for refractory hematological malignancies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Therapeutic advancement of chronic lymphocytic leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Tumor Immunotherapy Directed at PD-1

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Structures of PD-1 with its ligands: sideways and dancing cheek to cheek

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1 and its ligands in tolerance and immunity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1 and PD-1 ligands: from discovery to clinical application

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1/PD-L pathway and autoimmunity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

PD-1 inhibits antiviral immunity at the effector phase in the liver

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Expression of programmed death 1 ligands by murine T cells and APC

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Activation-induced expression of human programmed death-1 gene in T-lymphocytes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Structure and chromosomal localization of the human PD-1 gene (PDCD1)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

6 September 2017

Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

14 September 2017

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

26 June 2018

Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

26 June 2018

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3851976

retrieved

2 September 2018

Identifiers

DOI

10.1186/1756-8722-6-74

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

Dimensions Publication ID

1051135651

0 references

PMC publication ID

3851976

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

PubMed publication ID

24283718

1 reference

stated in

Europe PubMed Central

PMC publication ID

3851976

retrieved

20 August 2017

ResearchGate publication ID

258956986

0 references

 

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37365776&oldid=1304567504"